临床医生在美国东南部的心血管预防实践中自我报告的疗效
Trevor Caldarera1, Cynthia Ponir1, Austin Seals2
1Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA.
Future cardiology
|November 2, 2023
概括
临床医生在心血管预防方面的自我有效性因专业而异. 虽然对基本的生活方式和药物建议充满信心,但许多人对管理复杂的脂质障碍缺乏信心,这表明需要有针对性的支持.
科学领域:
- 心血管医学 心血管医学
- 医疗保健专业教育 医疗保健专业教育
- 临床实践 临床实践
背景情况:
- 预防心血管疾病是初级保健的基石.
- 临床医生的自我有效性影响了采用基于证据的预防策略.
- 了解不同专业的自我有效性对于优化心血管保健至关重要.
研究的目的:
- 评估临床医生在心血管预防实践中自我报告的自我有效性.
- 为了比较内部医学,家庭医学,内分泌学和心脏病学专家的自我有效性水平.
- 在心血管风险管理中确定高和低自我有效性的特定领域.
主要方法:
- 通过电子邮件向956名医疗保健提供者 (医生,执业护士,医生助理,药剂师) 发送了21项问卷.
- 应答率为27.6% (264名临床医生).
- 数据分析侧重于各个心血管预防领域的自我报告的疗效.
主要成果:
- 在生活方式咨询和处方常见的初级预防药物 (他类药物,甲型胺,阿司匹林) 中报告了高自我效率.
- 对于管理特殊疾病,如脂蛋白升高的低自我有效性被注意到.
- 初级保健提供者 (PCP) 报告说,与专家相比,在晚期脂质疾病中自我效率较低,但在开处方新型糖尿病药物 (SGLT2抑制剂,GLP-1RA) 中自我效率更高.
结论:
- 临床医师在心血管预防方面的自我有效性在各个医学专业中并不统一.
- 存在自我有效性的差距,特别是在管理复杂的脂质障碍时.
- 需要对提供者,诊所和系统因素进行进一步的调查,以加强心血管预防工作.
相关概念视频
Assessment of the Cardiovascular System I: Subjective Data
345
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
345
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9


